Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.
about
Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway.Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway.Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.
P2860
Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Somatostatin derivative (smsDX ...... androgen deprivation therapy.
@ast
Somatostatin derivative (smsDX ...... androgen deprivation therapy.
@en
Somatostatin derivative
@nl
type
label
Somatostatin derivative (smsDX ...... androgen deprivation therapy.
@ast
Somatostatin derivative (smsDX ...... androgen deprivation therapy.
@en
Somatostatin derivative
@nl
prefLabel
Somatostatin derivative (smsDX ...... androgen deprivation therapy.
@ast
Somatostatin derivative (smsDX ...... androgen deprivation therapy.
@en
Somatostatin derivative
@nl
P2093
P2860
P1433
P1476
Somatostatin derivative (smsDX ...... androgen deprivation therapy.
@en
P2093
Anders Holmberg
Sten Nilsson
Xiaoyu Guo
Zhaoquan Xing
Zhaoxin Guo
Zhaoxu Liu
Zhenghui Fang
Zhiqing Fang
P2860
P304
P356
10.1371/JOURNAL.PONE.0055790
P407
P577
2013-02-07T00:00:00Z